Jacqueline D Reses
CIK 1699681 · Executive Chairperson · last filed 2026-08-11
Jacqueline D Reses is an Executive Chairperson who has filed 86 SEC Form 4 insider transactions across 8 companies since 2017. The most recent filing, for NU, was dated Aug 11, 2026. Across all open-market trades the lifetime net is −$45.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions. 6 SEC filings were submitted jointly with Endeavor Group Holdings, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SQ price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1455 MARKET STREET #600
SAN FRANCISCO, CA 94103
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NU | Director | 45,754 | $14.56 | $666.2K | $0 | 1 | 2026-08-11 |
| AFRM | Director | 49,456 | $74.01 | $3.66M | $0 | 12 | 2026-07-06 |
| TASK | Director | 47,039 | $8.22 | $386.7K | -$496.6K | 7 | 2026-05-26 |
| Endeavor Group Holdings, Inc. (EDR) Delisted | Director | 23,103 | $29.25 | $675.8K | $0 | 4 | 2024-06-14 |
| ContextLogic Inc. (WISH) Delisted | Executive Chairperson | 706 | $5.13 | $3.6K | -$22.1K | 4 | 2021-12-21 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted | 100,000 | $2.02 | $202.0K | $0 | 1 | 2021-01-11 | |
| Block, Inc. (SQ) Delisted | Capital Lead | 204,272 | $86.96 | $17.76M | -$45.24M | 55 | 2020-10-05 |
| SPCE | Director | 5,000 | $2.43 | $12.2K | $0 | 1 | 2019-10-29 |
Recent Filings
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-11 | NU | Grant (A) | +27,096 | $0 | EDGAR |
| 2026-07-06 | AFRM | Grant (A) | +655 | $0 | EDGAR |
| 2026-05-26 | TASK | Exer (M) | +12,491 | $0 | EDGAR |
| 2025-12-17 | AFRM | Grant (A) | +3,579 | $0 | EDGAR |
| 2025-07-03 | AFRM | Grant (A) | +670 | $0 | EDGAR |
| 2025-05-27 | TASK | Mixed | +14,342 | $0 | EDGAR |
| 2025-03-26 | — | Mixed | −23,103 | $0 | |
| 2024-12-12 | AFRM | Grant (A) | +3,015 | $0 | EDGAR |
| 2024-07-02 | AFRM | Grant (A) | +1,508 | $0 | EDGAR |
| 2024-06-14 | Endeavor Group Holdings, Inc. (EDR) Delisted | Mixed | +8,125 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.